4-IPP
CAS No. 41270-96-6
4-IPP ( 4-Iodo-6-phenylpyrimidine )
产品货号. M21584 CAS No. 41270-96-6
4-IPP 是巨噬细胞迁移抑制因子 (MIF) 的不可逆抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥504 | 有现货 |
|
| 10MG | ¥844 | 有现货 |
|
| 25MG | ¥1423 | 有现货 |
|
| 50MG | ¥2111 | 有现货 |
|
| 100MG | ¥2925 | 有现货 |
|
| 200MG | ¥4113 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥938 | 有现货 |
|
生物学信息
-
产品名称4-IPP
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述4-IPP 是巨噬细胞迁移抑制因子 (MIF) 的不可逆抑制剂。
-
产品描述4-IPP is an irreversible?inhibitor of macrophage migration inhibitory factor (MIF).
-
体外实验Cell Cytotoxicity Assay Cell Line:BMMs Concentration:0.5 μM, 1 μM, 2.5 μM, 5 μM, 10 μM, 25 μM, 50 μM, 100 μM, 200 μM Incubation Time:24 hours, 72 hours Result:Inhibited osteoclastogenesis in a dose-dependent manner.Western Blot Analysis Cell Line:BMMs Concentration:5 μM,10 μM, 20 μM Incubation Time:1 day, 3 days, 5 days Result:Inhibited RANKL-induced osteoclast differentiation and bone resorption.
-
体内实验Animal Model:8-weeks-old C57BL/6J male mice Dosage:1 mg/kg, 5 mg/kg Administration:Intraperitoneal injection; every 2 days; for 8 weeks Result:Alleviated OVX-induced osteoporosis.
-
同义词4-Iodo-6-phenylpyrimidine
-
通路Others
-
靶点Other Targets
-
受体MIF
-
研究领域——
-
适应症——
化学信息
-
CAS Number41270-96-6
-
分子量282.08
-
分子式C10H7IN2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (354.51 mM)
-
SMILESIc1cc(ncn1)-c1ccccc1
-
化学全称4-Iodo-6-phenyl-pyrimidine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Zheng L et al. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway. FASEB J. 2019 Jun;33(6):7667-7683.
产品手册
关联产品
-
Kuwanon B
Kuwanon B 是一种黄酮衍生物,存在于栽培桑树 (Morus alba L. 的变种)根皮中。
-
Hepcidin-20 (human) ...
Hepcidin-20 (human) 是一种含有组氨酸、富含半胱氨酸的 β-折叠结构肽。Hepcidin-20 (human) 表现出抗真菌活性。Hepcidin-20 (human) 抑制多糖细胞间粘附素 (PIA) 阳性和 PIA 阴性菌株的生物膜形成和细菌细胞代谢 [3].
-
MM 07
Apelin biased agonist; exhibits bias for the G protein pathway. Stimulates endothelial NOS phosphorylation and expression, promotes proliferation, and attenuates apoptosis of human pulmonary arterial endothelial cells in vitro. Shows positive inotropic and vasodilatory effects in vivo and improves cardiac structure and function in a model of pulmonary arterial hypertension.
021-51111890
购物车()
sales@molnova.cn

